View in EDS HTML Full Text PDF Full Text

Real-world data of polatuzumab vedotin with bendamustine and rituximab for Japanese relapsed and refractory DLBCL: a multicenter retrospective study.

Saved in:
Bibliographic Details
Title: Real-world data of polatuzumab vedotin with bendamustine and rituximab for Japanese relapsed and refractory DLBCL: a multicenter retrospective study.
Authors: Fujino, Takahiro1 (AUTHOR), Okamoto, Haruya1 (AUTHOR), Nishiyama, Daichi2 (AUTHOR), Hayata, Hiroki2 (AUTHOR), Sasaki, Nana3 (AUTHOR), Kobayashi, Tsutomu4 (AUTHOR), Maekura, Chika1,5 (AUTHOR), Kuwahara-Ota, Saeko6 (AUTHOR), Takimoto-Shimomura, Tomoko7 (AUTHOR), Shimura, Kazuho8 (AUTHOR), Kawaji-Kanayama, Yuka1 (AUTHOR), Inoue, Yu1 (AUTHOR), Chinen, Shotaro1 (AUTHOR), Isa, Reiko1,8 (AUTHOR), Tsukamoto, Taku1 (AUTHOR), Mizutani, Shinsuke1 (AUTHOR), Shimura, Yuji1,9 (AUTHOR), Kaneko, Hiroto8 (AUTHOR), Nakao, Mitsushige7 (AUTHOR), Fuchida, Shinichi6 (AUTHOR)
Source: Leukemia & Lymphoma. Aug2025, Vol. 66 Issue 8, p1425-1436. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10428194
DOI:10.1080/10428194.2025.2483390